Treatment of Cushing's disease in children.
D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000616:Aminoglutethimide / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D002648:Child; D003480:Cushing Syndrome / Q000628:therapy*; D003533:Cyproheptadine / Q000627:therapeutic use; D013196:Dihydrotestosterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008797:Metyrapone / Q000627:therapeutic use; D008939:Mitotane / Q000627:therapeutic use; D010902:Pituitary Gland / Q000528:radiation effects / Q000601:surgery; D014635:Valproic Acid / Q000627:therapeutic use
D013196:Dihydrotestosterone; D000616:Aminoglutethimide; D003533:Cyproheptadine; D001971:Bromocriptine; D014635:Valproic Acid; D008939:Mitotane; D000324:Adrenocorticotropic Hormone; C009954:trilostane; D008797:Metyrapone